According to CytomX Therapeutics 's latest financial reports the company's total liabilities are โฌ62.35 Million. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-12-31 | โฌ0.11 B | -48.43% |
2023-12-31 | โฌ0.22 B | -30.23% |
2022-12-31 | โฌ0.32 B | 7.68% |
2021-12-31 | โฌ0.30 B | 0.73% |
2020-12-31 | โฌ0.29 B | 15.01% |
2019-12-31 | โฌ0.25 B | -9.17% |
2018-12-31 | โฌ0.28 B | 4.4% |
2017-12-31 | โฌ0.27 B | 138.15% |
2016-12-31 | โฌ0.11 B | 76.28% |
2015-12-31 | โฌ65.06 M | -47.8% |
2014-12-31 | โฌ0.12 B | 194.46% |
2013-12-31 | โฌ42.33 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | โฌ19.62 M | -68.52% | ๐บ๐ธ USA |